Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (118)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Posnett, D. N.
Right arrow Articles by Marodon, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Posnett, D. N.
Right arrow Articles by Marodon, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 2, 229-241, February 1999
© 1999 Japanese Society for Immunology

Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+CD28 cytotoxic effector clones

David N. Posnett, James W. Edinger, J. Sanil Manavalan, Craig Irwin and Gilles Marodon

Immunology Program, Graduate School of Medical Sciences, and the Department of Medicine, Cornell University, Weill Medical College, 1300 York Avenue, Box 56, New York, NY 10021

Correspondence to: D. N. Posnett

CD8 T cells contain a distinct subset of CD8+CD28 cells. These cells are not present at birth and their frequency increases with age. They frequently contain expanded clones using various TCR{alpha}ß receptors and these clones can represent >50% of all CD8 cells, specially in old subjects or patients with chronic viral infections such as HIV-1. Herein, it is shown that a large fraction of CD8+CD28 cells expresses intracellular perforin by three-color flow cytometry, in particular when this subset is expanded. Together with their known ability to exert potent re-directed cytotoxicity, this indicates that CD8+CD28 T cells comprise cytotoxic effector cells. With BrdU labeling, we show that CD8+CD28 cells derive from CD8+CD28+ precursors in vitro. In addition, sorted CD8+CD28+ cells gave rise to a population of CD8+CD28 cells after allo-stimulation. Moreover, ex vivo CD8+CD28+ cells contain the majority of CD8 blasts, supporting the notion that they contain the proliferative precursors of CD8+CD28 cells. CD95 (Fas) expression was lower in CD8+CD28 cells, and this subset was less prone to spontaneous apoptosis in ex vivo samples and more resistant to activation-induced cell death induced by a superantigen in vitro. Thus, the persistence of expanded clones in vivo in the CD8+CD28 subset may be explained by antigen-driven differentiation from CD8+CD28+ memory precursors, with relative resistance to apoptosis as the clones become perforin+ effector cells.

Keywords: age, apoptosis, CD8, CD28, human, oligoclonal, TCR

Transmitting editor: A. Singer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Inokuma, C. dela Rosa, C. Schmitt, P. Haaland, J. Siebert, D. Petry, M. Tang, M. A. Suni, S. A. Ghanekar, D. Gladding, et al.
Functional T Cell Responses to Tumor Antigens in Breast Cancer Patients Have a Distinct Phenotype and Cytokine Signature
J. Immunol., August 15, 2007; 179(4): 2627 - 2633.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. D. Wu, M. S. Maurer, R. A. Friedman, C. C. Marboe, E. M. Ruiz-Vazquez, R. Ramakrishnan, A. Schwartz, M. D. Tilson, A. S. Stewart, and R. Winchester
The Lymphocytic Infiltration in Calcific Aortic Stenosis Predominantly Consists of Clonally Expanded T Cells
J. Immunol., April 15, 2007; 178(8): 5329 - 5339.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. C. Beier, T. Kallinich, and E. Hamelmann
Master switches of T-cell activation and differentiation
Eur. Respir. J., April 1, 2007; 29(4): 804 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. K. Chiu, M. Fann, and N.-p. Weng
Generation and Growth of CD28nullCD8+ Memory T Cells Mediated by IL-15 and Its Induced Cytokines
J. Immunol., December 1, 2006; 177(11): 7802 - 7810.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Kobayashi, T. Kondo, H. Takata, S. Yokota, and M. Takiguchi
Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3.
J. Leukoc. Biol., August 1, 2006; 80(2): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Heydtmann, D. Hardie, P. L. Shields, J. Faint, C. D. Buckley, J. J. Campbell, M. Salmon, and D. H. Adams
Detailed Analysis of Intrahepatic CD8 T Cells in the Normal and Hepatitis C-Infected Liver Reveals Differences in Specific Populations of Memory Cells with Distinct Homing Phenotypes
J. Immunol., July 1, 2006; 177(1): 729 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Fletcher, M. Vukmanovic-Stejic, P. J. Dunne, K. E. Birch, J. E. Cook, S. E. Jackson, M. Salmon, M. H. Rustin, and A. N. Akbar
Cytomegalovirus-Specific CD4+ T Cells in Healthy Carriers Are Continuously Driven to Replicative Exhaustion
J. Immunol., December 15, 2005; 175(12): 8218 - 8225.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. Wikby, F. Ferguson, R. Forsey, J. Thompson, J. Strindhall, S. Lofgren, B.-O. Nilsson, J. Ernerudh, G. Pawelec, and B. Johansson
An Immune Risk Phenotype, Cognitive Impairment, and Survival in Very Late Life: Impact of Allostatic Load in Swedish Octogenarian and Nonagenarian Humans
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2005; 60(5): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Messaoudi, J. LeMaoult, J. A. Guevara-Patino, B. M. Metzner, and J. Nikolich-Zugich
Age-related CD8 T Cell Clonal Expansions Constrict CD8 T Cell Repertoire and Have the Potential to Impair Immune Defense
J. Exp. Med., November 15, 2004; 200(10): 1347 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. H. Undale, P. J. van den Elsen, and E. Celis
Antigen-independent acquisition of MHC class II molecules by human T lymphocytes
Int. Immunol., October 1, 2004; 16(10): 1523 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Wallace, Y. Zhang, H. Ghattas, A. Worth, A. Irvine, A. R. Bennett, G. E. Griffin, P. C. L. Beverley, D. F. Tough, and D. C. Macallan
Direct Measurement of T Cell Subset Kinetics In Vivo in Elderly Men and Women
J. Immunol., August 1, 2004; 173(3): 1787 - 1794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Lewis, M. Merched-Sauvage, J. J. Goronzy, C. M. Weyand, and A. N. Vallejo
Tumor Necrosis Factor-{alpha} and CD80 Modulate CD28 Expression through a Similar Mechanism of T-cell Receptor-independent Inhibition of Transcription
J. Biol. Chem., July 9, 2004; 279(28): 29130 - 29138.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Peacock and R. M. Welsh
Origin and Fate of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells Coexpressing the Inhibitory NK Cell Receptor Ly49G2
J. Immunol., July 1, 2004; 173(1): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Jankovic, I. Messaoudi, and J. Nikolich-Zugich
Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets
Blood, November 1, 2003; 102(9): 3244 - 3251.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. S. Topp, S. R. Riddell, Y. Akatsuka, M. C. Jensen, J. N. Blattman, and P. D. Greenberg
Restoration of CD28 Expression in CD28- CD8+ Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
J. Exp. Med., September 15, 2003; 198(6): 947 - 955.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Amyes, C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A. B. Rickinson, A. J. McMichael, and M. F.C. Callan
Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection
J. Exp. Med., September 15, 2003; 198(6): 903 - 911.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Geginat, A. Lanzavecchia, and F. Sallusto
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines
Blood, June 1, 2003; 101(11): 4260 - 4266.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. J. Warrington, A. N. Vallejo, C. M. Weyand, and J. J. Goronzy
CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation
Blood, May 1, 2003; 101(9): 3543 - 3549.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Bigouret, T. Hoffmann, L. Arlettaz, J. Villard, M. Colonna, A. Ticheli, A. Gratwohl, K. Samii, B. Chapuis, N. Rufer, et al.
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors
Blood, April 15, 2003; 101(8): 3198 - 3204.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Voehringer, M. Koschella, and H. Pircher
Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)
Blood, November 15, 2002; 100(10): 3698 - 3702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-J. Kim, R. R. Brutkiewicz, and H. E. Broxmeyer
Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
Blood, October 16, 2002; 100(9): 3253 - 3260.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Walzer, C. Arpin, L. Beloeil, and J. Marvel
Differential In Vivo Persistence of Two Subsets of Memory Phenotype CD8 T Cells Defined by CD44 and CD122 Expression Levels
J. Immunol., March 15, 2002; 168(6): 2704 - 2711.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. Holznagel, S. Norley, S. Holzammer, C. Coulibaly, and R. Kurth
Immunological changes in simian immunodeficiency virus (SIVagm)-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIVagm
J. Gen. Virol., March 1, 2002; 83(3): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Pitcher, S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker
Development and Homeostasis of T Cell Memory in Rhesus Macaque
J. Immunol., January 1, 2002; 168(1): 29 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Suresh, J. K. Whitmire, L. E. Harrington, C. P. Larsen, T. C. Pearson, J. D. Altman, and R. Ahmed
Role of CD28-B7 Interactions in Generation and Maintenance of CD8 T Cell Memory
J. Immunol., November 15, 2001; 167(10): 5565 - 5573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Nishio, M. Suzuki, N. Miyasaka, and H. Kohsaka
Clonal Biases of Peripheral CD8 T Cell Repertoire Directly Reflect Local Inflammation in Polymyositis
J. Immunol., October 1, 2001; 167(7): 4051 - 4058.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson
EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function
J. Immunol., August 15, 2001; 167(4): 2019 - 2029.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. A. Trimble, L. W. Kam, R. S. Friedman, Z. Xu, and J. Lieberman
CD3zeta and CD28 down-modulation on CD8 T cells during viral infection
Blood, August 1, 2000; 96(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
V. Appay, D. F. Nixon, S. M. Donahoe, G. M.A. Gillespie, T. Dong, A. King, G. S. Ogg, H. M.L. Spiegel, C. Conlon, C. A. Spina, et al.
HIV-specific CD8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
J. Exp. Med., July 3, 2000; 192(1): 63 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Pittet, D. E. Speiser, D. Valmori, J.-C. Cerottini, and P. Romero
Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
J. Immunol., February 1, 2000; 164(3): 1148 - 1152.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. J. Pittet, D. Valmori, P. R. Dunbar, D. E. Speiser, D. Lienard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.-C. Cerottini, and P. Romero
High Frequencies of Naive Melan-A/MART-1–specific CD8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (HLA)-A2 Individuals
J. Exp. Med., September 6, 1999; 190(5): 705 - 716.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Labalette, E. Leteurtre, C. Thumerelle, C. Grutzmacher, B. Tourvieille, and J.-P. Dessaint
Peripheral human CD8+CD28+T lymphocytes give rise to CD28–progeny, but IL-4 prevents loss of CD28 expression
Int. Immunol., August 1, 1999; 11(8): 1327 - 1336.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.